Transplantation of Autologously Derived Mitochondria Following Ischemia

Description

The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.

Conditions

Extracorporeal Membrane Oxygenation Complication

Study Overview

Study Details

Study overview

The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.

Transplantation of Autologously Derived Mitochondria for Protection Against Ischemia-reperfusion Injury Following Ischemia in Subjects on ECMO Support

Transplantation of Autologously Derived Mitochondria Following Ischemia

Condition
Extracorporeal Membrane Oxygenation Complication
Intervention / Treatment

-

Contacts and Locations

Boston

Boston Children's Hospital, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Pediatric cardiology patients under the age of 18 on ECMO
  • * concerns for ischemic injury on the Cardiac Intensive Care Unit
  • * Known mitochondria disorders

Ages Eligible for Study

to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Boston Children's Hospital,

Sitaram M Emani, MD, PRINCIPAL_INVESTIGATOR, Boston Children's Hospital

Study Record Dates

2025-06